Global Osimertinib Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Osimertinib Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Osimertinib by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Osimertinib by Country/Region, 2017, 2022 & 2028

2.2 Osimertinib Segment by Type

2.2.1 40mg*30 Tablets

2.2.2 80mg*30 Tablets

2.2.3 40mg*10 Tablets

2.2.4 80mg*10 Tablets

2.3 Osimertinib Sales by Type

2.3.1 Global Osimertinib Sales Market Share by Type (2017-2022)

2.3.2 Global Osimertinib Revenue and Market Share by Type (2017-2022)

2.3.3 Global Osimertinib Sale Price by Type (2017-2022)

2.4 Osimertinib Segment by Application

2.4.1 Locally Advanced NSCLC

2.4.2 Metastatic NSCLC

2.4.3 Other

2.5 Osimertinib Sales by Application

2.5.1 Global Osimertinib Sale Market Share by Application (2017-2022)

2.5.2 Global Osimertinib Revenue and Market Share by Application (2017-2022)

2.5.3 Global Osimertinib Sale Price by Application (2017-2022)

3 Global Osimertinib by Company

3.1 Global Osimertinib Breakdown Data by Company

3.1.1 Global Osimertinib Annual Sales by Company (2020-2022)

3.1.2 Global Osimertinib Sales Market Share by Company (2020-2022)

3.2 Global Osimertinib Annual Revenue by Company (2020-2022)

3.2.1 Global Osimertinib Revenue by Company (2020-2022)

3.2.2 Global Osimertinib Revenue Market Share by Company (2020-2022)

3.3 Global Osimertinib Sale Price by Company

3.4 Key Manufacturers Osimertinib Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Osimertinib Product Location Distribution

3.4.2 Players Osimertinib Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Osimertinib by Geographic Region

4.1 World Historic Osimertinib Market Size by Geographic Region (2017-2022)

4.1.1 Global Osimertinib Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Osimertinib Annual Revenue by Geographic Region

4.2 World Historic Osimertinib Market Size by Country/Region (2017-2022)

4.2.1 Global Osimertinib Annual Sales by Country/Region (2017-2022)

4.2.2 Global Osimertinib Annual Revenue by Country/Region

4.3 Americas Osimertinib Sales Growth

4.4 APAC Osimertinib Sales Growth

4.5 Europe Osimertinib Sales Growth

4.6 Middle East & Africa Osimertinib Sales Growth

5 Americas

5.1 Americas Osimertinib Sales by Country

5.1.1 Americas Osimertinib Sales by Country (2017-2022)

5.1.2 Americas Osimertinib Revenue by Country (2017-2022)

5.2 Americas Osimertinib Sales by Type

5.3 Americas Osimertinib Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Osimertinib Sales by Region

6.1.1 APAC Osimertinib Sales by Region (2017-2022)

6.1.2 APAC Osimertinib Revenue by Region (2017-2022)

6.2 APAC Osimertinib Sales by Type

6.3 APAC Osimertinib Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Osimertinib by Country

7.1.1 Europe Osimertinib Sales by Country (2017-2022)

7.1.2 Europe Osimertinib Revenue by Country (2017-2022)

7.2 Europe Osimertinib Sales by Type

7.3 Europe Osimertinib Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Osimertinib by Country

8.1.1 Middle East & Africa Osimertinib Sales by Country (2017-2022)

8.1.2 Middle East & Africa Osimertinib Revenue by Country (2017-2022)

8.2 Middle East & Africa Osimertinib Sales by Type

8.3 Middle East & Africa Osimertinib Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Osimertinib

10.3 Manufacturing Process Analysis of Osimertinib

10.4 Industry Chain Structure of Osimertinib

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Osimertinib Distributors

11.3 Osimertinib Customer

12 World Forecast Review for Osimertinib by Geographic Region

12.1 Global Osimertinib Market Size Forecast by Region

12.1.1 Global Osimertinib Forecast by Region (2023-2028)

12.1.2 Global Osimertinib Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Osimertinib Forecast by Type

12.7 Global Osimertinib Forecast by Application

13 Key Players Analysis

13.1 AstraZeneca

13.1.1 AstraZeneca Company Information

13.1.2 AstraZeneca Osimertinib Product Offered

13.1.3 AstraZeneca Osimertinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AstraZeneca Main Business Overview

13.1.5 AstraZeneca Latest Developments

13.2 Incepta Pharmaceuticals Limited

13.2.1 Incepta Pharmaceuticals Limited Company Information

13.2.2 Incepta Pharmaceuticals Limited Osimertinib Product Offered

13.2.3 Incepta Pharmaceuticals Limited Osimertinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Incepta Pharmaceuticals Limited Main Business Overview

13.2.5 Incepta Pharmaceuticals Limited Latest Developments

13.3 Everest Pharmaceuticals

13.3.1 Everest Pharmaceuticals Company Information

13.3.2 Everest Pharmaceuticals Osimertinib Product Offered

13.3.3 Everest Pharmaceuticals Osimertinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Everest Pharmaceuticals Main Business Overview

13.3.5 Everest Pharmaceuticals Latest Developments

13.4 Beacon Pharma

13.4.1 Beacon Pharma Company Information

13.4.2 Beacon Pharma Osimertinib Product Offered

13.4.3 Beacon Pharma Osimertinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Beacon Pharma Main Business Overview

13.4.5 Beacon Pharma Latest Developments

13.5 Drug International

13.5.1 Drug International Company Information

13.5.2 Drug International Osimertinib Product Offered

13.5.3 Drug International Osimertinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Drug International Main Business Overview

13.5.5 Drug International Latest Developments

14 Research Findings and Conclusion

Table 1. Osimertinib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Osimertinib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 40mg*30 Tablets

Table 4. Major Players of 80mg*30 Tablets

Table 5. Major Players of 40mg*10 Tablets

Table 6. Major Players of 80mg*10 Tablets

Table 7. Global Osimertinib Sales by Type (2017-2022) & (K Pcs)

Table 8. Global Osimertinib Sales Market Share by Type (2017-2022)

Table 9. Global Osimertinib Revenue by Type (2017-2022) & ($ million)

Table 10. Global Osimertinib Revenue Market Share by Type (2017-2022)

Table 11. Global Osimertinib Sale Price by Type (2017-2022) & (USD/Pcs)

Table 12. Global Osimertinib Sales by Application (2017-2022) & (K Pcs)

Table 13. Global Osimertinib Sales Market Share by Application (2017-2022)

Table 14. Global Osimertinib Revenue by Application (2017-2022)

Table 15. Global Osimertinib Revenue Market Share by Application (2017-2022)

Table 16. Global Osimertinib Sale Price by Application (2017-2022) & (USD/Pcs)

Table 17. Global Osimertinib Sales by Company (2020-2022) & (K Pcs)

Table 18. Global Osimertinib Sales Market Share by Company (2020-2022)

Table 19. Global Osimertinib Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Osimertinib Revenue Market Share by Company (2020-2022)

Table 21. Global Osimertinib Sale Price by Company (2020-2022) & (USD/Pcs)

Table 22. Key Manufacturers Osimertinib Producing Area Distribution and Sales Area

Table 23. Players Osimertinib Products Offered

Table 24. Osimertinib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Osimertinib Sales by Geographic Region (2017-2022) & (K Pcs)

Table 28. Global Osimertinib Sales Market Share Geographic Region (2017-2022)

Table 29. Global Osimertinib Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Osimertinib Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Osimertinib Sales by Country/Region (2017-2022) & (K Pcs)

Table 32. Global Osimertinib Sales Market Share by Country/Region (2017-2022)

Table 33. Global Osimertinib Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Osimertinib Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Osimertinib Sales by Country (2017-2022) & (K Pcs)

Table 36. Americas Osimertinib Sales Market Share by Country (2017-2022)

Table 37. Americas Osimertinib Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Osimertinib Revenue Market Share by Country (2017-2022)

Table 39. Americas Osimertinib Sales by Type (2017-2022) & (K Pcs)

Table 40. Americas Osimertinib Sales Market Share by Type (2017-2022)

Table 41. Americas Osimertinib Sales by Application (2017-2022) & (K Pcs)

Table 42. Americas Osimertinib Sales Market Share by Application (2017-2022)

Table 43. APAC Osimertinib Sales by Region (2017-2022) & (K Pcs)

Table 44. APAC Osimertinib Sales Market Share by Region (2017-2022)

Table 45. APAC Osimertinib Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Osimertinib Revenue Market Share by Region (2017-2022)

Table 47. APAC Osimertinib Sales by Type (2017-2022) & (K Pcs)

Table 48. APAC Osimertinib Sales Market Share by Type (2017-2022)

Table 49. APAC Osimertinib Sales by Application (2017-2022) & (K Pcs)

Table 50. APAC Osimertinib Sales Market Share by Application (2017-2022)

Table 51. Europe Osimertinib Sales by Country (2017-2022) & (K Pcs)

Table 52. Europe Osimertinib Sales Market Share by Country (2017-2022)

Table 53. Europe Osimertinib Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Osimertinib Revenue Market Share by Country (2017-2022)

Table 55. Europe Osimertinib Sales by Type (2017-2022) & (K Pcs)

Table 56. Europe Osimertinib Sales Market Share by Type (2017-2022)

Table 57. Europe Osimertinib Sales by Application (2017-2022) & (K Pcs)

Table 58. Europe Osimertinib Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Osimertinib Sales by Country (2017-2022) & (K Pcs)

Table 60. Middle East & Africa Osimertinib Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Osimertinib Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Osimertinib Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Osimertinib Sales by Type (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Osimertinib Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Osimertinib Sales by Application (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Osimertinib Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Osimertinib

Table 68. Key Market Challenges & Risks of Osimertinib

Table 69. Key Industry Trends of Osimertinib

Table 70. Osimertinib Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Osimertinib Distributors List

Table 73. Osimertinib Customer List

Table 74. Global Osimertinib Sales Forecast by Region (2023-2028) & (K Pcs)

Table 75. Global Osimertinib Sales Market Forecast by Region

Table 76. Global Osimertinib Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Osimertinib Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Osimertinib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 79. Americas Osimertinib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Osimertinib Sales Forecast by Region (2023-2028) & (K Pcs)

Table 81. APAC Osimertinib Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Osimertinib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Europe Osimertinib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Osimertinib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Middle East & Africa Osimertinib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Osimertinib Sales Forecast by Type (2023-2028) & (K Pcs)

Table 87. Global Osimertinib Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Osimertinib Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Osimertinib Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Osimertinib Sales Forecast by Application (2023-2028) & (K Pcs)

Table 91. Global Osimertinib Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Osimertinib Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Osimertinib Revenue Market Share Forecast by Application (2023-2028)

Table 94. AstraZeneca Basic Information, Osimertinib Manufacturing Base, Sales Area and Its Competitors

Table 95. AstraZeneca Osimertinib Product Offered

Table 96. AstraZeneca Osimertinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 97. AstraZeneca Main Business

Table 98. AstraZeneca Latest Developments

Table 99. Incepta Pharmaceuticals Limited Basic Information, Osimertinib Manufacturing Base, Sales Area and Its Competitors

Table 100. Incepta Pharmaceuticals Limited Osimertinib Product Offered

Table 101. Incepta Pharmaceuticals Limited Osimertinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 102. Incepta Pharmaceuticals Limited Main Business

Table 103. Incepta Pharmaceuticals Limited Latest Developments

Table 104. Everest Pharmaceuticals Basic Information, Osimertinib Manufacturing Base, Sales Area and Its Competitors

Table 105. Everest Pharmaceuticals Osimertinib Product Offered

Table 106. Everest Pharmaceuticals Osimertinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 107. Everest Pharmaceuticals Main Business

Table 108. Everest Pharmaceuticals Latest Developments

Table 109. Beacon Pharma Basic Information, Osimertinib Manufacturing Base, Sales Area and Its Competitors

Table 110. Beacon Pharma Osimertinib Product Offered

Table 111. Beacon Pharma Osimertinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 112. Beacon Pharma Main Business

Table 113. Beacon Pharma Latest Developments

Table 114. Drug International Basic Information, Osimertinib Manufacturing Base, Sales Area and Its Competitors

Table 115. Drug International Osimertinib Product Offered

Table 116. Drug International Osimertinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 117. Drug International Main Business

Table 118. Drug International Latest Developments

List of Figures

Figure 1. Picture of Osimertinib

Figure 2. Osimertinib Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Osimertinib Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Osimertinib Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Osimertinib Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 40mg*30 Tablets

Figure 10. Product Picture of 80mg*30 Tablets

Figure 11. Product Picture of 40mg*10 Tablets

Figure 12. Product Picture of 80mg*10 Tablets

Figure 13. Global Osimertinib Sales Market Share by Type in 2021

Figure 14. Global Osimertinib Revenue Market Share by Type (2017-2022)

Figure 15. Osimertinib Consumed in Locally Advanced NSCLC

Figure 16. Global Osimertinib Market: Locally Advanced NSCLC (2017-2022) & (K Pcs)

Figure 17. Osimertinib Consumed in Metastatic NSCLC

Figure 18. Global Osimertinib Market: Metastatic NSCLC (2017-2022) & (K Pcs)

Figure 19. Osimertinib Consumed in Other

Figure 20. Global Osimertinib Market: Other (2017-2022) & (K Pcs)

Figure 21. Global Osimertinib Sales Market Share by Application (2017-2022)

Figure 22. Global Osimertinib Revenue Market Share by Application in 2021

Figure 23. Osimertinib Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Osimertinib Revenue Market Share by Company in 2021

Figure 25. Global Osimertinib Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Osimertinib Revenue Market Share by Geographic Region in 2021

Figure 27. Global Osimertinib Sales Market Share by Region (2017-2022)

Figure 28. Global Osimertinib Revenue Market Share by Country/Region in 2021

Figure 29. Americas Osimertinib Sales 2017-2022 (K Pcs)

Figure 30. Americas Osimertinib Revenue 2017-2022 ($ Millions)

Figure 31. APAC Osimertinib Sales 2017-2022 (K Pcs)

Figure 32. APAC Osimertinib Revenue 2017-2022 ($ Millions)

Figure 33. Europe Osimertinib Sales 2017-2022 (K Pcs)

Figure 34. Europe Osimertinib Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Osimertinib Sales 2017-2022 (K Pcs)

Figure 36. Middle East & Africa Osimertinib Revenue 2017-2022 ($ Millions)

Figure 37. Americas Osimertinib Sales Market Share by Country in 2021

Figure 38. Americas Osimertinib Revenue Market Share by Country in 2021

Figure 39. United States Osimertinib Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Osimertinib Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Osimertinib Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Osimertinib Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Osimertinib Sales Market Share by Region in 2021

Figure 44. APAC Osimertinib Revenue Market Share by Regions in 2021

Figure 45. China Osimertinib Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Osimertinib Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Osimertinib Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Osimertinib Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Osimertinib Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Osimertinib Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Osimertinib Sales Market Share by Country in 2021

Figure 52. Europe Osimertinib Revenue Market Share by Country in 2021

Figure 53. Germany Osimertinib Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Osimertinib Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Osimertinib Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Osimertinib Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Osimertinib Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Osimertinib Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Osimertinib Revenue Market Share by Country in 2021

Figure 60. Egypt Osimertinib Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Osimertinib Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Osimertinib Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Osimertinib Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Osimertinib Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Osimertinib in 2021

Figure 66. Manufacturing Process Analysis of Osimertinib

Figure 67. Industry Chain Structure of Osimertinib

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles